BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32057572)

  • 1. CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine.
    Gary EN; Kathuria N; Makurumidze G; Curatola A; Ramamurthi A; Bernui ME; Myles D; Yan J; Pankhong P; Muthumani K; Haddad E; Humeau L; Weiner DB; Kutzler MA
    Vaccine; 2020 Mar; 38(11):2626-2635. PubMed ID: 32057572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 virus-like particles.
    Rainone V; Dubois G; Temchura V; Überla K; Clivio A; Nebuloni M; Lauri E; Trabattoni D; Veas F; Clerici M
    PLoS One; 2011; 6(10):e26979. PubMed ID: 22066023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue.
    Hu K; Luo S; Tong L; Huang X; Jin W; Huang W; Du T; Yan Y; He S; Griffin GE; Shattock RJ; Hu Q
    J Immunol; 2013 Aug; 191(4):1935-47. PubMed ID: 23858028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosa-associated epithelial chemokine/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control.
    Cha HR; Ko HJ; Kim ED; Chang SY; Seo SU; Cuburu N; Ryu S; Kim S; Kweon MN
    J Immunol; 2011 Sep; 187(6):3044-52. PubMed ID: 21832166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL28 involvement in mucosal tissues protection as a chemokine and as an antibacterial peptide.
    Berri M; Virlogeux-Payant I; Chevaleyre C; Melo S; Zanello G; Salmon H; Meurens F
    Dev Comp Immunol; 2014 Jun; 44(2):286-90. PubMed ID: 24445014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection.
    Castelletti E; Lo Caputo S; Kuhn L; Borelli M; Gajardo J; Sinkala M; Trabattoni D; Kankasa C; Lauri E; Clivio A; Piacentini L; Bray DH; Aldrovandi GM; Thea DM; Veas F; Nebuloni M; Mazzotta F; Clerici M
    PLoS One; 2007 Oct; 2(10):e969. PubMed ID: 17912348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
    Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
    J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues.
    Meurens F; Berri M; Whale J; Dybvig T; Strom S; Thompson D; Brownlie R; Townsend HG; Salmon H; Gerdts V
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):313-27. PubMed ID: 16839611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae.
    Aldon Y; Kratochvil S; Shattock RJ; McKay PF
    J Immunol; 2020 Feb; 204(4):903-913. PubMed ID: 31915263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge.
    Kutzler MA; Wise MC; Hutnick NA; Moldoveanu Z; Hunter M; Reuter M; Yuan S; Yan J; Ginsberg A; Sylvester A; Pahar B; Carnathan D; Kathuria N; Khan AS; Montefiori D; Sardesai NY; Betts MR; Mestecky J; Marx P; Weiner DB
    Mucosal Immunol; 2016 Jan; 9(1):13-23. PubMed ID: 25943275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR10 and its ligands in regulation of epithelial immunity and diseases.
    Xiong N; Fu Y; Hu S; Xia M; Yang J
    Protein Cell; 2012 Aug; 3(8):571-80. PubMed ID: 22684736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.
    Domm W; Brooks L; Chung HL; Feng C; Bowers WJ; Watson G; McGrath JL; Dewhurst S
    Vaccine; 2011 Sep; 29(40):7080-9. PubMed ID: 21801777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines.
    Gary E; O'Connor M; Chakhtoura M; Tardif V; Kumova OK; Malherbe DC; Sutton WF; Haigwood NL; Kutzler MA; Haddad EK
    Vaccine; 2020 May; 38(22):3821-3831. PubMed ID: 32280045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
    Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
    Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.
    McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ
    J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.
    Fouda GG; Amos JD; Wilks AB; Pollara J; Ray CA; Chand A; Kunz EL; Liebl BE; Whitaker K; Carville A; Smith S; Colvin L; Pickup DJ; Staats HF; Overman G; Eutsey-Lloyd K; Parks R; Chen H; Labranche C; Barnett S; Tomaras GD; Ferrari G; Montefiori DC; Liao HX; Letvin NL; Haynes BF; Permar SR
    J Virol; 2013 Jun; 87(12):6986-99. PubMed ID: 23596289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.
    Bradney CP; Sempowski GD; Liao HX; Haynes BF; Staats HF
    J Virol; 2002 Jan; 76(2):517-24. PubMed ID: 11752142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal CCL28 Chemokine Improves Protection against Genital Herpes through Mobilization of Antiviral Effector Memory CCR10+CD44+ CD62L-CD8+ T Cells and Memory CCR10+B220+CD27+ B Cells into the Infected Vaginal Mucosa.
    Dhanushkodi NR; Prakash S; Quadiri A; Zayou L; Srivastava R; Tran J; Dang V; Shaik AM; Chilukurri A; Suzer B; Vera P; Sun M; Nguyen P; Lee A; Salem A; Loi J; Singer M; Nakayama T; Vahed H; Nesburn AB; BenMohamed L
    J Immunol; 2023 Jul; 211(1):118-129. PubMed ID: 37222480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.